Knowledge Centre
category guide

How to choose a Washer-Disinfector

May 2, 2026· 11 min read· AI-generated

How to choose a Washer-Disinfector

What sterile processing departments, ASCs, and dental practices need to know before committing capital to automated instrument reprocessing.


What this is and who buys it

A washer-disinfector (WD) is the automated workhorse at the front end of any instrument reprocessing workflow. Unlike a simple ultrasonic cleaner or manual scrub sink, a WD executes a validated, multi-phase cycle — typically pre-wash, enzymatic or detergent wash, one or more rinses, a thermal or chemical disinfection phase, and forced-air drying — in a closed chamber under controlled temperature and chemistry conditions. The goal is not sterilization but a reproducible, documented reduction in bioburden that makes downstream sterilization reliable and protects decontamination-zone staff from sharps and pathogen exposure.

The primary buyers are hospital Central Sterile Services Departments (CSSDs or SPDs), ambulatory surgery centers, GI endoscopy units, dental practices, oral surgery clinics, and clinical research laboratories. Each of these settings has different throughput demands, instrument portfolios, and regulatory exposure — a large hospital SPD serving 20 operating rooms faces a completely different procurement decision than a four-operatory dental practice. What they share is the need for a validated, auditable process that will survive a Joint Commission, CMS, or state health department survey.

Purchase decisions are most commonly triggered by one of four events: a new facility build-out, a throughput bottleneck caused by growing case volume, an expansion into instrument-intensive procedures (robotic surgery, advanced endoscopy), or a deficiency finding during a regulatory audit. In any of these scenarios, getting the specification wrong is expensive — both in capital terms and in the downstream cost of revalidation, utility retrofits, or instrument damage.


Key decision factors

Instrument compatibility and load configuration is the factor most frequently underspecified in early RFPs. A WD's chamber capacity is measured in DIN baskets (typical floor-standing units range from 8 to 28 DIN) or chamber volume (roughly 100 L to 500 L+), but raw capacity is less important than whether the unit is validated for your specific instrument mix. Lumened instruments, robotic EndoWrist arms, microsurgical sets, and anesthesia circuits each require dedicated rack adapters and cycle parameters that must be validated by the OEM — not assumed to transfer from a similar model.

Disinfection level and cycle validation determines whether a WD can function as a terminal processor or only as a pre-sterilization cleaning step. Thermal disinfection at 93°C per ISO 15883-2, delivering an A0 value of at least 600, is the standard for surgical instrument WDs used in hospital SPDs. Units marketed for high-level disinfection as a terminal process require FDA 510(k) clearance [S1]; those providing only low or intermediate-level disinfection may be 510(k)-exempt under 21 CFR 807.65(c) but cannot be used as the final processing step for critical or semi-critical devices. This distinction has direct legal and accreditation implications.

Throughput and cycle time is where procurement decisions most often create operational problems after installation. A standard surgical instrument cycle runs 30 to 90 minutes from door-close to door-open, including drying. If your SPD processes 80 instrument trays per day across a 10-hour shift, a single unit with a 60-minute cycle is mathematically insufficient. Floor-standing, dual-door pass-through models serve a second critical function beyond throughput: they enforce the physical barrier between the decontaminated and clean zones required by AAMI and ASHRAE ventilation guidelines — a distinction that single-door units cannot provide.

Water quality infrastructure is an under-budgeted line item in almost every procurement. WDs require demineralized or deionized (DI) water for the final rinse phase — mineral-laden tap water deposits residue on instruments, accelerates corrosion, and can introduce endotoxin. Floor-standing units typically require approximately 120 liters of water per cycle at specified flow rates and temperature ranges. Determine whether your building has existing DI or reverse-osmosis capacity, the current conductivity readings at the decontamination room supply, and whether an in-line softener or RO system is part of the WD package or a separate capital cost. Utility retrofits to meet these requirements commonly add $10,000 to $50,000 to the total installation cost.

Traceability and digital integration has moved from a "nice to have" to a compliance requirement. Joint Commission standard EC.02.04.01 and DNV accreditation require documented evidence of each processing cycle — operator ID, cycle parameters, temperature logs, and load contents. WDs with Ethernet or Wi-Fi connectivity, barcode or RFID load logging, and validated data exports to instrument tracking platforms (SPM, Censitrac, T-DOC, and similar systems) meet this requirement cleanly. Units that output only a paper printout or no record at all create an audit gap that is increasingly difficult to defend during surveys.

Detergent chemistry lock-in is a total-cost-of-ownership variable that rarely appears in the capital purchase analysis. Many OEMs validate their cycles exclusively with their own proprietary enzymatic and alkaline detergents, meaning that switching chemistry mid-contract requires full revalidation of affected cycles — a resource-intensive process under ANSI/AAMI ST15883-1. Before signing, model out multi-year detergent costs at your projected cycle volume, and ask explicitly whether the dosing system will accept third-party chemistry and under what co-validation conditions.

Electrical and utility requirements for floor-standing units typically include 208–240V three-phase power at 30–60 amps, a dedicated drain line, and both hot and cold water connections. These specifications must be confirmed against the decontamination room's current infrastructure before issuing an RFP, not after delivery.

Validated cycle library depth affects how quickly a unit can go into clinical use and how much validation work your team inherits. Industry norms range from 10 to 50 OEM-validated standard programs; every custom cycle developed outside that library requires independent revalidation per ANSI/AAMI ST15883-1, which is time-consuming and requires test soiling reagents, biological indicators, and documented OQ/PQ runs.


What it costs

WD pricing is not publicly listed by most major OEMs — list prices are typically quote-only and vary by region, GPO contract, and configuration. The ranges below reflect general market positioning; actual quotes may vary materially, and buyers should obtain at least three competitive bids.

  • Entry ($5,000–$20,000): Benchtop or compact single-chamber units for dental offices, small clinics, or low-volume labs. Pricing not consistently publicly disclosed — obtain quotes directly.
  • Mid ($20,000–$60,000): Single-chamber floor-standing units for ASCs, GI endoscopy suites, or mid-size SPDs. Pricing is similarly quote-driven and varies by cycle count and accessories.
  • Premium ($60,000–$150,000+): Dual-door pass-through, multi-chamber, or high-capacity CSSD units (≥15 DIN baskets). Large-hospital configurations with automation and integrated tracking can exceed $150,000; quotes only from OEMs such as Getinge, STERIS, Steelco Belimed, and Miele.

Common use cases

The device category spans a wide range of settings, and the right specification differs sharply by context.

  • Hospital CSSD/SPD: High-volume reprocessing of surgical trays, rigid containers, and anesthesia equipment; typically multiple floor-standing dual-door units in a validated barrier workflow.
  • Ambulatory Surgery Centers: Mid-size floor-standing models for same-day surgical instrument turnaround; ASCs are subject to the same infection control documentation standards as hospitals under CMS Conditions for Coverage.
  • Endoscopy / GI Units: Specialized automated endoscope reprocessors (AERs) validated for flexible scopes are classified separately as Class II devices under 21 CFR 876.1500 — these are distinct from general surgical instrument WDs and require their own 510(k) clearance.
  • Dental Practices and Oral Surgery Clinics: Benchtop WDs for handpieces, scalers, and cassette-based instrument sets, subject to CDC Guidelines for Infection Control in Dental Health-Care Settings.

Regulatory and compliance

The FDA classified medical washer-disinfectors as Class II devices (special controls) in a final rule published November 15, 2002 [S2]. The applicable special control is the FDA's "Class II Special Controls Guidance Document: Medical Washers and Medical Washer-Disinfectors" [S1], which outlines the performance data and labeling requirements manufacturers must meet. Units intended to provide high-level disinfection as a terminal process require 510(k) clearance before marketing; buyers should verify clearance by searching the FDA CDRH 510(k) database by product code (FRN) prior to procurement.

The primary performance and validation standards are ANSI/AAMI ST15883-1 (general requirements and validation methodology), ANSI/AAMI ST15883-2 (thermal disinfection specifics, including the A0 value requirement), and ISO 15883-5:2021 (cleaning efficacy test criteria). Water quality for final rinses is governed by AAMI TIR34. IEC 60601-1 covers general electrical safety for units with electronic controls. One compliance gap that often surprises facilities: ISO 15883 explicitly states that standard WD performance requirements do not ensure inactivation or removal of prion proteins. Facilities performing neurosurgery must maintain a separate, documented prion/TSE decontamination protocol independent of the WD workflow.


Service, training, and total cost of ownership

Installation of a floor-standing dual-door unit typically requires two to five working days for equipment placement plus separate lead time for plumbing, electrical, and drain connections — utility preparation should be scoped and costed before the equipment purchase order is issued. Once installed, the unit must pass Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) testing per ANSI/AAMI ST15883-1 before clinical use; expect three to ten days of validation testing depending on the number of instrument types and programmed cycles. OEM service engineers or qualified third-party biomedical firms can perform this work, but the cost — which is often not included in the equipment quote — should be budgeted separately.

Ongoing preventive maintenance intervals are typically every six to twelve months and include inspection of spray arms, pump seals, door gaskets, heating elements, and chemical dosing systems; monthly water quality conductivity logs are standard practice. Full-service OEM contracts generally run 8–12% of original purchase price per year. Third-party biomedical service organizations may offer 20–40% savings, but verify parts availability and confirm that emergency response time SLAs meet the ≤4-hour target for critical SPD equipment. Major OEMs typically guarantee parts availability for 10–15 years post-model discontinuation — get this in writing. Expected lifespan for a quality floor-standing unit with consistent PM is 10–15 years; end-of-life is most commonly triggered by control system obsolescence or inability to revalidate modified cycles, not mechanical failure.

Staff operating WDs should hold or be working toward the IAHCSMM Certified Registered Central Service Technician (CRCST) credential, which is the U.S. standard for SPD competency and is increasingly required by accreditation bodies. Documented training records on loading protocols, cycle selection, chemistry dosing, and alarm response are required for survey readiness.


Red flags to watch for

A vendor unable to produce a specific FDA 510(k) clearance number for the intended disinfection level is a hard stop — purchasing a WD marketed for high-level disinfection without verified clearance exposes the facility to regulatory action regardless of the vendor's assurances. Similarly, any proposal that involves running custom cycles not included in the OEM's validated cycle library without a plan for independent ANSI/AAMI ST15883-1 revalidation should be treated as a compliance liability, not a feature.

Watch for detergent "compatibility" claims unsupported by co-validation documentation. A vendor claiming that any enzymatic detergent will work with their unit's validated cycle — without a written co-validation data package — is shifting the cleaning efficacy risk to your facility. Relatedly, if the site assessment does not include a water quality review and the quote does not address DI/RO infrastructure, the project is likely to encounter expensive surprises post-installation. Finally, be cautious about units that offer only paper printout batch records or no cycle-data export at all; the accreditation landscape has moved decisively toward electronic traceability, and retrofitting this capability later is rarely straightforward.


Questions to ask vendors

  1. What is the specific FDA 510(k) clearance number for this model at the intended disinfection level, and can you provide the CDRH database listing? For endoscope models, what is the 21 CFR 876.1500 clearance reference?
  2. Which instrument types, tray configurations, and load weights are validated for each pre-programmed cycle, and how many OEM-validated cycles are included out of the box?
  3. What are the water quality specifications (conductivity, hardness, temperature) for each phase, and does the unit include a built-in water softener or DI filter, or is that a separate purchase?
  4. Which detergent and disinfectant products are co-validated with this WD, what is the projected annual chemistry cost at our cycle volume, and under what conditions are third-party chemistries acceptable?
  5. What is the complete cycle time — door-close to door-open including drying — for your standard surgical instrument cycle, and at our projected daily tray volume, how many units do you recommend to avoid throughput bottlenecks?
  6. What are the full warranty terms, the guaranteed parts availability period after model discontinuation, and the annual cost of a full-coverage preventive maintenance contract including emergency call-out?

Alternatives

The refurbished WD market can reduce capital outlay by 30–50% on floor-standing units, but the risk profile is higher than new: buyers must require documented IQ/OQ/PQ revalidation performed after refurbishment, written confirmation that the unit retains its original 510(k)-cleared configuration, a service history report, and a parts availability guarantee. Refurbished units carry the most risk for ASCs or small facilities without in-house biomedical engineering support; for a large hospital SPD with a strong biomed team, refurbished can be a defensible option if documentation requirements are contractually enforced.

  • Operating lease (36–60 months): Preserves capital, shifts maintenance to the lessor, and enables technology refresh at end of term. Total lease cost typically runs 15–25% above purchase price over the same period — worth modeling against your facility's cost of capital.
  • Capital purchase: Preferable for stable, long-tenure facilities with strong biomedical support and a GPO contract (Vizient, Premier, HealthTrust) that reduces acquisition cost.
  • Outsourced/offsite reprocessing: Small ASCs or dental groups running fewer than three cases per day may find that a contracted third-party CSSD is operationally and financially superior to owning a WD. Above approximately five OR cases per day, in-house reprocessing is typically more cost-effective on a per-tray basis.
  • Single-chamber dual-door vs. multi-chamber tunnel systems: Tunnel washers offer the highest throughput for large hospital CSSDs (20+ OR suites) but require significantly greater capital, floor space, and utility capacity. Single-chamber dual-door pass-through units remain the dominant configuration for most hospital SPDs processing up to 15–20 cases per day.

Sources

Sources

Browse vendors in

MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.